Gastric cancer adapts high lipid microenvironment via suppressing PPARG-FABP1 axis after arriving in the lymph node.
1/5 보강
[AIM] Gastric cancer (GC) primarily metastasizes through lymphatic channels, although lymphatic metastasis remains relatively inefficient.
APA
Liu Y, Tang L, et al. (2025). Gastric cancer adapts high lipid microenvironment via suppressing PPARG-FABP1 axis after arriving in the lymph node.. Redox biology, 85, 103759. https://doi.org/10.1016/j.redox.2025.103759
MLA
Liu Y, et al.. "Gastric cancer adapts high lipid microenvironment via suppressing PPARG-FABP1 axis after arriving in the lymph node.." Redox biology, vol. 85, 2025, pp. 103759.
PMID
40694956 ↗
Abstract 한글 요약
[AIM] Gastric cancer (GC) primarily metastasizes through lymphatic channels, although lymphatic metastasis remains relatively inefficient. Changes in cellular metabolism, known as metabolic reprogramming, plays a significant role in the adaptive survival of cells during the process. Therefore, understanding the mechanism underlying metabolic reprogramming in lymph node (LN) metastasis is crucial for the development of targeted therapies for advanced gastric cancer. This study aimed to investigate the metabolic adaptations of GC cells during LN metastasis, with a particular focus on lipid metabolism reprogramming.
[METHODS] Non-targeted lipidomic sequencing, combined with tumor cell flow sorting and RNA sequencing, was used to explore differences in lipid microenvironments and changes in lipid metabolism pathways between lymph nodes and primary tumors. Single-cell sequencing data were analyzed to confirm these results. Transmission electron microscopy, BODIPY 581/591 staining, and ferroptosis inhibitors were used to confirm the effects of arachidonic acid (AA) on ferroptosis sensitivity in gastric cancer. Public databases and ChIP-qPCR tests were used to investigate the role of PPARγ pathway in regulating FABP1 transcription.
[RESULTS] Lipid metabolism pathway was inhibited following lymph node metastasis, with reduced lipid catabolites observed in the lymph nodes. Single-cell data also supported these findings. Physiological concentrations of AA were shown to increase ferroptosis sensitivity, lipid peroxidation, and mitochondrial damage in gastric cancer cells. FABP1 was significantly downregulated in lymph nodes, which mediated the uptake of AA, mitochondrial destruction, and lipid peroxidation. Further analysis revealed that PPARγ, a regulator of FABP1 transcription, was significantly downregulated after lymph node metastasis. Furthermore, our findings revealed that AA reduced the stability of PPARγ protein.
[CONCLUSION] The high concentration of AA in the lymph nodes microenvironment can increase the sensitivity of gastric cancer cells to ferroptosis. Mechanically, AA inhibits the PPARγ pathway to downregulate FABP1 expression, thereby suppressing AA uptake and preventing ferroptosis of gastric cancer cells.
[METHODS] Non-targeted lipidomic sequencing, combined with tumor cell flow sorting and RNA sequencing, was used to explore differences in lipid microenvironments and changes in lipid metabolism pathways between lymph nodes and primary tumors. Single-cell sequencing data were analyzed to confirm these results. Transmission electron microscopy, BODIPY 581/591 staining, and ferroptosis inhibitors were used to confirm the effects of arachidonic acid (AA) on ferroptosis sensitivity in gastric cancer. Public databases and ChIP-qPCR tests were used to investigate the role of PPARγ pathway in regulating FABP1 transcription.
[RESULTS] Lipid metabolism pathway was inhibited following lymph node metastasis, with reduced lipid catabolites observed in the lymph nodes. Single-cell data also supported these findings. Physiological concentrations of AA were shown to increase ferroptosis sensitivity, lipid peroxidation, and mitochondrial damage in gastric cancer cells. FABP1 was significantly downregulated in lymph nodes, which mediated the uptake of AA, mitochondrial destruction, and lipid peroxidation. Further analysis revealed that PPARγ, a regulator of FABP1 transcription, was significantly downregulated after lymph node metastasis. Furthermore, our findings revealed that AA reduced the stability of PPARγ protein.
[CONCLUSION] The high concentration of AA in the lymph nodes microenvironment can increase the sensitivity of gastric cancer cells to ferroptosis. Mechanically, AA inhibits the PPARγ pathway to downregulate FABP1 expression, thereby suppressing AA uptake and preventing ferroptosis of gastric cancer cells.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Breast Morphological Comparison Between Anatomic and Round Implant Augmentation: A Prospective Study.
- Latent transforming growth factor beta binding protein 1 (LTBP1): roles as a multifunctional extracellular matrix regulator in human disease - from molecular mechanisms to clinical translation prospects.
- Association between body mass index and outcomes in lymphoma-associated haemophagocytic lymphohistiocytosis: A retrospective multicentre cohort study of Jiangsu Cooperative Lymphoma Group (JCLG).
- Single-cell and spatial transcriptome analysis of breast cancer tumor-associated fibroblast heterogeneity and its mediated remodeling of the tumor microenvironment.
- Spatial omics at the forefront: emerging technologies, analytical innovations, and clinical applications.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.